The relationship between adherence and quality of treatment with vitamin K antagonists [10]

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 2, 2004, Pages 362-363

  Locadia, M ^a   van Geest Daalderop, J H H ^a   Sprangers, M A G ^b   Hutten, B A ^a   Prins, M H ^c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Thrombosis Service's Hertogenbosch ^*  (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ANTIVITAMIN K; PHENPROCOUMON; VITAMIN K GROUP;

ADULT; AGED; CARDIOVASCULAR DISEASE; DRUG BLOOD LEVEL; HEALTH CARE QUALITY; HEART ATRIUM FIBRILLATION; HUMAN; LETTER; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PATIENT EDUCATION; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT; STATISTICAL SIGNIFICANCE; STROKE; DRUG ANTAGONISM; NOTE; TREATMENT OUTCOME;

ACENOCOUMAROL; ATRIAL FIBRILLATION; HUMANS; PATIENT COMPLIANCE; TREATMENT OUTCOME; VITAMIN K;

EID: 4644275215     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7933.2004.0584j.x     Document Type: Letter

References (6)

1. Van Walraven C, Hart RG, Singer DE, Laupacis A, Connolly S, Petersen P, Koudstaal PJ, Chang Y, Hellemons B. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation. An individual patient meta-analysis. JAMA 2002; 288: 2441-8.
2. Van der Meer FJM, Briët E, Vandenbroucke JP, Šrámek DI. The role of compliance as a cause of instability in oral anticoagulant therapy. Br J Haematol 1997; 98: 893-900.
3. Laporte S, Quenet S, Buchmüller-Cordier A, Reynaud J, Tardy-Poncet B, Thirion C, Decousus H, Mismetti P. Compliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trial. Thromb Haemost 2003; 89: 458-67.
4. Rosendaal FR, Cannegieter SC, van der Meer FJM, Briët E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993; 69: 236-9.
5. Hutten BA, Prins MH, Redekop WK, Tijssen JG, Heisterkamp SH, Büller HR. Comparison of three methods to assess therapeutic quality control of treatment with vitamin K antagonists. Thromb Haemost 1999; 82: 1260-3.
6. Nieuwkerk PT, Sprangers MA, Burger DM, Hoetelmans RM, Hugen PW, Danner SA, van Der Ende ME, Schneider MM, Schrey G, Meenhorst PL, Sprenger HG, Kauffmann RH, Jambroes M, Chesney MA, de Wolf F, Lange JM for the ATHENA Project. Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study. Arch Intern Med 2001; 161: 1926-8.